Continuous glucose monitoring system developer Dexcom (NSDQ:DXCM) announced today that it priced an upsized offering worth $1.05 billion in convertible senior notes. Yesterday, the San Diego-based company announced an offering worth $850 million with plans to offer note purchasers a 13-day option to buy up to an additional $150 million aggregate principal amount of notes. Today, […]
Dexcom
Dexcom to raise $850m from senior notes offering
Dexcom (NSDQ:DXCM) said today that it plans to offer an $850 million aggregate principal amount of convertible senior notes due 2025. The San Diego-based continuous glucose monitoring systems company also plans to offer note purchasers a 13-day option to buy up to an additional $150 million aggregate principal amount of notes. Dexcom plans to use $600 […]
Dexcom shares up on Street-beating Q1 results
Dexcom (NSDQ:DXCM) posted first-quarter results today that beat the consensus forecast on Wall Street but dropped its financial guidance for the year. The San Diego-based continuous glucose monitoring systems company reported profits of $19.9 million, or 21¢ per share, on sales of $405.1 million for the three months ended March 31 on sales growth of 44.4% […]
Dexcom appoints senior VP of finance and chief accounting officer
Dexcom (NSDQ:DXCM) this week said it appointed Jereme Sylvain as senior VP of finance and chief accounting officer, which took effect on March 9. Sylvain will be the accounting officer for purposes of the rules and regulations of the Securities and Exchange Commission. Prior to his appointment, Sylvain was Dexcom’s VP and corporate controller and […]
Dexcom lands CE Mark for continuous glucose monitor use by pregnant women
Dexcom (NSDQ:DXCM) said Friday that its G6 continuous glucose monitor system has received the CE Mark for use during pregnancy, and will be available soon, starting with the United Kingdom in Spring 2020. Glucose levels are hard to manage in pregnancy due to the increasing need for and resistance to insulin. Poorly controlled glucose levels in […]
Insulet partners with Abbott and Dexcom on automated insulin delivery
Abbott (NYSE:ABT) and Dexcom (NSDQ:DXCM) each announced today that they are partnering with Insulet (NSDQ:PODD) to feed blood glucose monitor data into an automated insulin delivery system. For Acton, Mass.–based Insulet, the agreements are a boost for its next-generation Omnipod Horizon automated insulin delivery system, which is presently an investigational device in the United States. The idea of […]
Dexcom skyrockets on Street-beating Q4
Dexcom (NSDQ:DXCM) shares took a big jump up today on fourth-quarter results that topped the consensus forecast with relative ease and improved upon losses from the company’s previous fourth quarter. Shares of DXCM were up 13.8% at $286.96 per share in late-morning trading today. The San Diego–based continuous glucose monitor maker posted profits of $92.7 million, […]
Lilly to integrate DexCom CGMs in automated dosing system
Eli Lilly (NYSE:LLY) announced that it will integrate Dexcom (NSDQ:DXCM) products into its personalized diabetes management system, now under development. Under the new, non-exclusive agreement, Indianapolis-based Lilly will use San Diego-based Dexcom’s continuous glucose monitoring (CGM) devices in pen-based and pump-based platforms in Lily’s diabetes management system. The pen-based platform is designed to integrate personalized data from […]
Dexcom CEO apologizes for remote monitoring outage
Dexcom (NSDQ:DXCM) CEO Kevin Sayer publicly apologized on Friday for an outage over Thanksgiving weekend that cut off users’ ability to share glucose monitoring data with caregivers and loved ones. The Dexcom Follow app normally allows users of the company’s G6 continuous glucose monitor to share that data with up to 10 people, according to the company’s […]
FDA approves Tandem Diabetes’ advanced hybrid closed-loop controller
The FDA today cleared the Tandem Diabetes Care (NSDQ:TNDM) t:slim X2 insulin pump and Control-IQ advanced hybrid closed-loop technology to control Type 1 diabetes. The agency also granted De Novo clearance to the Control-IQ device, which is compatible with a variety of continuous glucose monitors and insulin pumps. The t:slim system, which also includes the recently approved Dexcom […]
Dexcom jumps after hours on Q3 Street-beating earnings
Dexcom (NSDQ:DXCM) shares jumped after hours today on third-quarter results that bettered the consensus forecast. The San Diego–based continuous glucose monitoring system developer posted profits of $45.8 million, or 50¢ per share, on sales of $396.3 million for the three months ended Sept. 30, for a 1.7% bottom-line slide on sales growth of 48.6%. Adjusted to […]